CVS Health Files 8-K Report

Ticker: CVS · Form: 8-K · Filed: Sep 22, 2025 · CIK: 64803

Cvs Health CORP 8-K Filing Summary
FieldDetail
CompanyCvs Health CORP (CVS)
Form Type8-K
Filed DateSep 22, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing, financials

TL;DR

CVS filed an 8-K, likely with financial updates. Check for details.

AI Summary

CVS Health Corporation filed an 8-K on September 22, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details about the nature of these events or financial figures within the provided text.

Why It Matters

This filing indicates that CVS Health has submitted a report to the SEC, which may contain material updates or financial information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural report and does not disclose any immediate negative events or financial distress.

Key Players & Entities

FAQ

What specific 'Other Events' are reported in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.

What financial statements or exhibits are included with this filing?

The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided text.

When was this 8-K report filed with the SEC?

This 8-K report was filed on September 22, 2025.

What is the principal executive office address for CVS HEALTH Corporation?

The address of the principal executive offices is One CVS Drive, Woonsocket, Rhode Island, 02895.

What is the Commission File Number for CVS HEALTH Corporation?

The Commission File Number for CVS HEALTH Corporation is 001-01011.

Filing Stats: 608 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-09-22 16:19:42

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: September 22, 2025 By: /s/ Kristina V. Fink Kristina V. Fink Senior Vice President, Secretary and Chief Governance Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing